Nachrichten

bioMérieux launches the BIOFIRE® FILMARRAY® Pneumonia Panels with FDA clearance and CE Marking

13 November, 2018

bioMérieux, a world leader in the field of in vitro diagnostics, today announced the Food and Drug Administration (FDA) 510(k) clearance of the BIOFIRE® FILMARRAY® Pneumonia Panel and the CE-Mark of the BIOFIRE® FILMARRAY® Pneumonia Panel plus. The BIOFIRE® FILMARRAY®...

z.B. 11/14/2019
z.B. 11/14/2019

Cepheid and bioMérieux enter into strategic commercial program

06 Januar, 2004

bioMerieux to Apply Cepheid Platform Technology to NASBA Amplification Technology.

Pioneering Diagnostics